| 22.19 -0.28 (-1.25%) | 10-06 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 26.26  |
1-year : | 27.13 |
| Resists | First : | 22.48 |
Second : | 23.22 |
| Pivot price | 22.44 |
|||
| Supports | First : | 21.28 |
Second : | 17.71 |
| MAs | MA(5) : | 22.15 |
MA(20) : | 22.42 |
| MA(100) : | 25.56 |
MA(250) : | 25.5 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.6 |
| %K %D | K(14,3) : | 39.7 |
D(3) : | 30.5 |
| RSI | RSI(14): 42.9 |
|||
| 52-week | High : | 37.77 | Low : | 14 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ TCMD ] has closed above bottom band by 30.4%. Bollinger Bands are 70.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 20 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 22.71 - 22.84 | 22.84 - 22.96 |
| Low: | 21.62 - 21.76 | 21.76 - 21.89 |
| Close: | 21.99 - 22.21 | 22.21 - 22.42 |
Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.
Tue, 06 Oct 2026
MarketBeat gives Tactile Systems Technology stock a Moderate Buy consensus - AD HOC NEWS
Mon, 05 Oct 2026
Tactile Systems Technology stock gains after Q2 earnings beat - AD HOC NEWS
Mon, 05 Oct 2026
Tactile Systems Technology, Inc. (NASDAQ:TCMD) Stock Now Rated "Moderate Buy" by Wall Street Brokerages - MarketBeat
Fri, 02 Oct 2026
52,370 Shares of Tactile Systems Technology, Inc. $TCMD Purchased by Bank of America Corp DE - MarketBeat
Tue, 11 Aug 2026
Tactile Systems Technology Shares Fall After Q2 Results, Lowered 2026 Revenue Guidance - Yahoo Finance
Mon, 10 Aug 2026
Tactile Systems Technology, Inc. Reports Second Quarter 2026 Financial Results - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 23 (M) |
| Shares Float | 21 (M) |
| Held by Insiders | 2.2 (%) |
| Held by Institutions | 105.1 (%) |
| Shares Short | 2,550 (K) |
| Shares Short P.Month | 2,450 (K) |
| EPS | 1.07 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 9.85 |
| Profit Margin | 7 % |
| Operating Margin | 7.9 % |
| Return on Assets (ttm) | 7.9 % |
| Return on Equity (ttm) | 11.8 % |
| Qtrly Rev. Growth | 8.6 % |
| Gross Profit (p.s.) | 11.87 |
| Sales Per Share | 15.46 |
| EBITDA (p.s.) | 1.84 |
| Qtrly Earnings Growth | 144.1 % |
| Operating Cash Flow | 31 (M) |
| Levered Free Cash Flow | 14 (M) |
| PE Ratio | 20.73 |
| PEG Ratio | 17.7 |
| Price to Book value | 2.25 |
| Price to Sales | 1.43 |
| Price to Cash Flow | 16.45 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|